Survival of patients with pacing-induced cardiomyopathy upgraded to CRT does not depend on defibrillation therapy.

Danuta LobodaMichal GibinskiKarolina ZietekJacek WilczekRafal Gardas Krzysztof S GołbaKrzysztof S Golba

Published in: Pacing and clinical electrophysiology : PACE (2020)

Advanced age and an extremely low LVEF, but neither the presence of atrial fibrillation nor implanting an additional high voltage lead, influence the all-cause mortality in patients after long-term RVP, when upgraded to CRT.

Keyphrases

cardiac resynchronization therapy
end stage renal disease
atrial fibrillation
heart failure
ejection fraction
chronic kidney disease
newly diagnosed
cardiac arrest
peritoneal dialysis
prognostic factors
patient reported outcomes
oxidative stress
mesenchymal stem cells
replacement therapy